Safety and cost analysis of early discharge following percutaneous coronary intervention for acute coronary syndrome in patients with diabetes mellitus

被引:0
|
作者
Li, Shihong [1 ]
Li, Zhizhong [1 ]
Hou, Xuejian [1 ]
Sun, Junping [1 ]
Kang, Lihui [1 ]
Cheng, Yutong [1 ]
Tao, Ying [1 ]
Li, Zhao [1 ]
Chen, Xuanzu [1 ]
Zhang, Donghua [1 ]
Yan, Xianliang [1 ]
Wang, Su [1 ]
Gao, Yulong [1 ]
Wang, Qian [1 ]
Lin, Yun [1 ]
Yin, Chengqian [1 ]
Zhang, Jingmei [1 ]
Gao, Yun [1 ]
Huang, Ji [1 ]
Wu, Xiangyu [1 ]
Li, Nan [1 ]
Su, Wang [1 ]
Liu, Honghong [1 ]
Sun, Tao [1 ]
机构
[1] Capital Med Univ, Beijing Zhen Hosp, Dept Cardiol, 2 Anzhen Rd, Beijing 100029, Peoples R China
关键词
Diabetes mellitus; safety and cost; acute coronary syndrome; percutaneous coronary intervention; early discharge; hospitalization; ELEVATION MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; SAME-DAY DISCHARGE; LENGTH-OF-STAY; HEART-DISEASE; CARDIOVASCULAR-ANGIOGRAPHY; ARTERY-DISEASE; IMPACT; REVASCULARIZATION; METAANALYSIS;
D O I
10.1177/0300060519842777
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective To evaluate the safety and cost of early discharge compared with ordinary discharge in patients with diabetes mellitus (DM) following percutaneous coronary intervention (PCI) for acute coronary syndrome. Methods We performed a retrospective analysis of prospectively collected data from 474 patients with DM who were discharged from hospital following PCI at a regional center between 2012 and 2015. Results A total of 192 patients (40.5%) were included in the early discharge group and 282 patients (59.5%) were included in the ordinary group. Mortality and morbidity after PCI were recorded. Kaplan-Meier analysis showed similar prognosis between the two groups at 30 days and at 1 year after discharge. However, hospitalization expenses for the regular discharge group were significantly higher than those of the early discharge group (RMB65,750 vs. RMB50,983). Conclusion Our findings demonstrate that early discharge of patients with DM following PCI for acute coronary syndrome is safe compared with ordinary discharge, and may reduce hospitalization costs.
引用
收藏
页码:3905 / 3917
页数:13
相关论文
共 50 条
  • [21] Utilization of Percutaneous Coronary Intervention in Cancer Patients With Acute Coronary Syndrome - A Nationwide Analysis
    Shah, Nishi N.
    Pothineni, Naga Venkata K.
    Rochlani, Yogita
    Bhatti, Sabah
    Iliescu, Cesar
    Marmagkiolis, Konstantinos
    Hakeem, Abdul
    CIRCULATION, 2015, 132
  • [22] Adherence and Persistence with Prasugrel Following Acute Coronary Syndrome with Percutaneous Coronary Intervention
    Nordstrom, Beth L.
    Simeone, Jason C.
    Zhao, Zhenxiang
    Molife, Cliff
    McCollam, Patrick L.
    Ye, Xin
    Effron, Mark B.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2013, 13 (04) : 263 - 271
  • [23] Adherence and Persistence with Prasugrel Following Acute Coronary Syndrome with Percutaneous Coronary Intervention
    Beth L. Nordstrom
    Jason C. Simeone
    Zhenxiang Zhao
    Cliff Molife
    Patrick L. McCollam
    Xin Ye
    Mark B. Effron
    American Journal of Cardiovascular Drugs, 2013, 13 : 263 - 271
  • [24] Role of beta blockers following percutaneous coronary intervention for acute coronary syndrome
    Peck, Kah Yong
    Andrianopoulos, Nick
    Dinh, Diem
    Roberts, Louise
    Duffy, Stephen J.
    Sebastian, Martin
    Clark, David
    Brennan, Angela
    Oqueli, Ernesto
    Ajani, Andrew E.
    Reid, Christopher M.
    Freeman, Melanie
    Teh, Andrew W.
    HEART, 2021, 107 (09) : 728 - 733
  • [25] Safety of percutaneous coronary intervention in patients with acute ischemic stroke/transient ischemic attack and acute coronary syndrome
    Zeus, Tobias
    Ketterer, Ulrike
    Leuf, Daniela
    Dannenberg, Lisa
    Boenner, Florian
    Wagstaff, Rabea
    Gliem, Michael
    Jander, Sebastian
    Kelm, Malte
    Polzin, Amin
    CLINICAL RESEARCH IN CARDIOLOGY, 2016, 105 (04) : 356 - 363
  • [26] Safety of percutaneous coronary intervention in patients with acute ischemic stroke/transient ischemic attack and acute coronary syndrome
    Tobias Zeus
    Ulrike Ketterer
    Daniela Leuf
    Lisa Dannenberg
    Florian Bönner
    Rabea Wagstaff
    Michael Gliem
    Sebastian Jander
    Malte Kelm
    Amin Polzin
    Clinical Research in Cardiology, 2016, 105 : 356 - 363
  • [27] Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin
    Ramana, Ravi K.
    Lewis, Bruce E.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (03) : 493 - 505
  • [28] Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
    Gilyarov, M. Yu
    Konstantinova, E., V
    Atabegashvili, M. R.
    Solntseva, T. D.
    Anichkov, D. A.
    Kostina, A. N.
    Polybin, R., V
    Udovichenko, A. E.
    Svet, A., V
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2021, 17 (02) : 221 - 227
  • [29] Percutaneous Coronary Intervention for Bifurcation Lesions in Patients With Acute Coronary Syndrome
    Choudhary, Rahul
    Deora, Surender
    Kaushik, Atul
    Sharma, Jai B.
    CIRCULATION, 2020, 142
  • [30] Prognosis of patients with acute coronary syndrome submitted to percutaneous coronary intervention
    Sousa, P. J.
    Teles, R. C.
    Goncalves, P. A.
    Almeida, M. S.
    Cale, R.
    Brito, J.
    Raposo, L.
    Palos, J. L.
    Baptista, J.
    Silva, J. A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 361 - 361